Christine Slover, PharmD discussed cefiderocol's effectiveness against challenging infections, including those caused by multi-drug resistant bacteria.
Christine Slover PharmD
Advertisement
Executive Medical Director for Anti-Infectives at Shionogi Inc.
Articles by Christine Slover PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
2
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
3
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
4
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
5
